MEDICENNA THERA CORP by Medicenna Therapeutics Corp. (MDNAF)

About MEDICENNA THERA CORP by Medicenna Therapeutics Corp. (MDNAF)

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

MEDICENNA THERA CORP by Medicenna Therapeutics Corp. News